Search Results - "Kim, Alfred H.J."

Refine Results
  1. 1

    Cardiac Manifestations of Systemic Lupus Erythematosus by Miner, Jonathan J., MD, PhD, Kim, Alfred H.J., MD, PhD

    “…Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder that manifests with multiorgan inflammation. Cardiac involvement is common, with…”
    Get full text
    Journal Article
  2. 2

    Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know by Yazdany, Jinoos, Kim, Alfred H J

    Published in Annals of internal medicine (02-06-2020)
    “…Two medications often used for treatment of immune-mediated conditions, hydroxychloroquine and chloroquine, have recently attracted widespread interest as…”
    Get full text
    Journal Article
  3. 3

    A Pharmacokinetics‐Informed Approach to Navigating Hydroxychloroquine Shortages in Patients With Rheumatic Disease During the COVID‐19 Pandemic by Scheetz, Marc H., Konig, Maximilian F., Robinson, Philip C., Sparks, Jeffrey A., Kim, Alfred H.J.

    Published in ACR open rheumatology (01-08-2020)
    “…Objective The recent hydroxychloroquine (HCQ) shortage due to use in coronavirus disease 2019 (COVID‐19) has forced some rheumatic disease patients to choose…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    From mechanism to therapies in systemic lupus erythematosus by Paley, Michael A, Strand, Vibeke, Kim, Alfred H.J

    Published in Current opinion in rheumatology (01-03-2017)
    “…PURPOSE OF REVIEWSystemic lupus erythematosus (SLE) is a disabling and deadly disease. Development of novel therapies for SLE has historically been limited by…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Exploring intentional medication non-adherence in patients with systemic lupus erythematosus: the role of physician–patient interactions by Leung, Jerik, Baker, Elizabeth A, Kim, Alfred H J

    Published in Rheumatology advances in practice (01-01-2021)
    “…Abstract Objective Medication non-adherence contributes to worse health outcomes among SLE patients. The underlying mechanisms that drive medication…”
    Get full text
    Journal Article
  10. 10
  11. 11

    New approaches in renal microscopy: volumetric imaging and superresolution microscopy by Kim, Alfred H.J, Suleiman, Hani, Shaw, Andrey S

    “…PURPOSE OF REVIEWHistologic and electron microscopic analysis of the kidney has provided tremendous insight into structures such as the glomerulus and nephron…”
    Get full text
    Journal Article
  12. 12

    Anxiety Symptoms Among Patients With Systemic Lupus Erythematosus Persist Over Time and Are Independent of SLE Disease Activity by Lew, Daphne, Huang, Xinliang, Kellahan, Sara R., Xian, Hong, Eisen, Seth, Kim, Alfred H. J.

    Published in ACR open rheumatology (01-05-2022)
    “…Objective The objectives of this study are to identify patterns of anxiety symptomology over time among patients with systemic lupus erythematosus (SLE) and to…”
    Get full text
    Journal Article
  13. 13

    New roles revealed for T cells and DCs in glomerulonephritis by Kim, Alfred H J, Markiewicz, Mary A, Shaw, Andrey S

    Published in The Journal of clinical investigation (01-05-2009)
    “…Little is known about the potential role of T cells in the inflammatory renal disease glomerulonephritis (GN). GN has been historically viewed as a product of…”
    Get full text
    Journal Article
  14. 14
  15. 15

    COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations by Grainger, Rebecca, Kim, Alfred H. J., Conway, Richard, Yazdany, Jinoos, Robinson, Philip C.

    Published in Nature reviews. Rheumatology (01-04-2022)
    “…The COVID-19 pandemic has brought challenges for people with rheumatic disease in addition to those faced by the general population, including concerns about…”
    Get full text
    Journal Article
  16. 16

    The Role of Complement in Autoimmune Disease-Associated Thrombotic Microangiopathy and the Potential for Therapeutics by Java, Anuja, Kim, Alfred H J

    Published in Journal of rheumatology (01-06-2023)
    “…The complement system is a tightly regulated, cascading protein network representing a key component linking the innate and humoral immune systems. However, if…”
    Get full text
    Journal Article
  17. 17

    Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: Systematic review and meta-analysis by Jena, Anuraag, Mishra, Shubhra, Deepak, Parakkal, Kumar-M, Praveen, Sharma, Aman, Patel, Yusuf I., Kennedy, Nicholas A., Kim, Alfred H.J., Sharma, Vishal, Sebastian, Shaji

    Published in Autoimmunity reviews (01-01-2022)
    “…The treatment for COVID-19 often utilizes immune-modulating drugs. These drugs are also used in immune mediated inflammatory diseases (IMIDs). We performed a…”
    Get full text
    Journal Article
  18. 18
  19. 19

    The complement system in COVID-19: friend and foe? by Java, Anuja, Apicelli, Anthony J, Liszewski, M Kathryn, Coler-Reilly, Ariella, Atkinson, John P, Kim, Alfred Hj, Kulkarni, Hrishikesh S

    Published in JCI insight (06-08-2020)
    “…Coronavirus disease 2019 (COVID-19), the disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has resulted in a global pandemic and a…”
    Get full text
    Journal Article
  20. 20